BioCentury
ARTICLE | Company News

Selah Genomics, Greenville Health System sales and marketing update

February 8, 2016 8:00 AM UTC

Selah Genomics launched the mySUDDinCode test in the U.S. to determine the risk of sudden cardiac death. Selah said the test, which analyzes 55 genes related to sudden cardiac death, costs $2,999 but ...